Drug Combo Targets Common Cystic Fibrosis Gene AbnormalityDrug Combo Targets Common Cystic Fibrosis Gene Abnormality

Results from the phase 3 TRAFFIC and TRANSPORT trials suggest the oral combination of lumacaftor and ivacaftor improves lung function and curbs exacerbations. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news